Evaluation of selected agents in TR-fret assays for selected kinase targets
Ended Purchase Order Awarded
- Contract number
- 75N95022P00400
- Awardee
-
Enzymlogic SL. UEI GRR1LT3KX4G5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $129,720
Award facts
- Contract value 100% obligated
- $129,720.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Spain
Award details come from SAM.gov/FPDS.
About this award
This is a federal purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Center for Advancing Translational Sciences, to Enzymlogic SL, a for-profit, woman-owned business located in Spain. The contract is for the evaluation of selected agents in time-resolved fluorescence energy transfer (TR-FRET) assays for selected kinase targets, with a firm fixed price of $129,720.00 and a completion date of March 15, 2023. The contract does not have a set-aside designation. Enzymlogic SL is a leading analytical contract research organization for drug discovery that has provided similar services to NIH agencies in the past, such as profiling of Bruton's tyrosine kinase (BTK) inhibitors and evaluation of agents for the National Institute on Drug Abuse.
Quick answers
Who was awarded contract 75N95022P00400?
75N95022P00400 was awarded to Enzymlogic SL. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2022.
How much is contract 75N95022P00400 worth?
The government has obligated $129,720 on 75N95022P00400.
Which agency awarded contract 75N95022P00400?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00400, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00400 competed?
The extent of competition for 75N95022P00400 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award